Cellerant gets $36.4M for stem cell-based radiation syndrome therapy

09/5/2012 | Genetic Engineering & Biotechnology News

The Biomedical Advanced Research and Development Authority awarded Cellerant Therapeutics a $36.4 million grant to help further develop CLT-008, an allogeneic stem cell-based treatment for acute radiation syndrome. The funding is part of a five-year grant that could total $169.9 million. Cellerant will put the money toward ongoing clinical and nonclinical studies, as well as process development and manufacturing.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC